Quantcast

Latest Immunohistochemistry Stories

2011-10-03 19:39:58

Researchers have determined that a combination of P16 immunohistochemistry and DNA qPCR to test for viral E6 can accurately determine the oropharyngeal squamous cell carcinoma, a form of head and neck cancer, which derive from HPV16, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This has immediate clinical applications as we consider recruitment to clinical trials designed to de-escalate the intensity of therapy...

2011-08-02 07:00:00

TUCSON, Ariz., Aug. 2, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the launch of BenchMark ULTRA with new Ultimate Reagent Access (URA). BenchMark ULTRA with URA is the world's first platform that allows laboratories to process individual immunohistochemistry (IHC) and in situ hybridization (ISH) samples as soon as they arrive in the lab. This enhancement allows labs to quickly respond to unpredictable changes in workflow,...

2011-07-26 07:00:00

TUCSON, Ariz., July 26, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the launch of their OptiView DAB IHC Detection Kit, the first fully-automated immunohistochemistry (IHC) detection kit that combines both sensitive chemistry and flexible software to deliver highly customizable staining. OptiView Detection significantly enhances stain quality, allowing pathologists to view IHC assays more clearly than ever before. (Photo:...

2011-06-28 10:56:00

IRVINE, Calif., June 28, 2011 /PRNewswire/ -- GeneTex, a leading manufacturer of high quality antibodies, is pleased to announce that they will be launching a full line of zebrafish antibodies. Zebrafish have been increasingly utilized as a model organism for scientific research. Due to their short lifecycles and relatively large clutch sizes, they are a useful model for genetic studies. Zebrafish eggs are externally fertilized; therefore, researchers can control and manipulate the...

2011-06-14 17:56:00

TUCSON, Ariz., June 14, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today that the FDA approved the INFORM HER2 Dual ISH DNA Probe cocktail assay (HER2 Dual ISH) for commercialization in the United States. This is the first fully automated assay approved by the FDA for determination of HER2 gene status in breast cancer as an aid in the assessment of patients considered for treatment with Herceptin (trastuzumab). For breast cancer...

2011-03-29 07:00:00

EXTON, Pa., March 29, 2011 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has entered into a collaboration and license agreement with Biocare Medical, LLC. Under the agreement, the parties will collaborate to develop and commercialize an immunohistochemical (IHC) diagnostic kit utilizing Morphotek's proprietary monoclonal antibody to specifically detect human folate receptor alpha (FRA) with Biocare's intelliPATH(TM) Automated...

2011-03-03 07:25:13

(Ivanhoe Newswire) --  Lung cancer is considered the 6th most common cause of cancer deaths in the United States.  Overall, 10-15% of lung cancers occur in people who have never smoked a single cigarette in their life.  But thanks to an inexpensive and rapid testing method, scientists can now efficiently identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence. It's a new test...

2011-02-25 13:14:17

European Multidisciplinary Conference in Thoracic Oncology news An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found. Dr Ping Yang from the Mayo Clinic, Rochester, USA, and colleagues, reported the findings at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), 24-26 February 2011,...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related